For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

New medication that can cut body weight by 23% could radically reduce the number of people who are obese. Tirzepatide is ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Gaffigan admitted to having trepidation to use the medication, a brand name for tirzepatide, after tipping the scales at 270 ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

A few different active ingredients are used to support weight loss. We’ll go over the most popular ones — semaglutide, liraglutide, and tirzepatide — below. Both metformin and Ozempic can ...